• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用PITCh系统生成具有可预测的CYP3A4、UGT1A1和CES代谢的Caco-2细胞。

Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system.

作者信息

Yamada Naoki, Negoro Ryosuke, Watanabe Keita, Fujita Takuya

机构信息

Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Noji-Higashi, Kusatsu, 525-8577, Japan.

Laboratory of Molecular Pharmacokinetics, College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Noji-Higashi, Kusatsu, 525-8577, Japan.

出版信息

Drug Metab Pharmacokinet. 2023 Jun;50:100497. doi: 10.1016/j.dmpk.2023.100497. Epub 2023 Feb 18.

DOI:10.1016/j.dmpk.2023.100497
PMID:37037169
Abstract

Caco-2 cells are widely used as an in vitro intestinal model. However, the expression levels of the drug-metabolizing enzymes CYP3A4 and UGT1A1 are lower in these cells than in intestinal cells. Furthermore, the majority of prodrugs in use today are ester-containing, and carboxylesterase (CES) 1 and CES2 are among the enzymes that process the prodrugs into drugs. In the human small intestine, CES1 is hardly expressed while CES2 is highly expressed, but the CES expression pattern in Caco-2 cells is the opposite. In this study, we generated CYP3A4-POR-UGT1A1-CES2 knock-in (KI) and CES1 knock-out (KO) Caco-2 (genome-edited Caco-2) cells using a PITCh system. Genome-edited Caco-2 cells were shown to express functional CYP3A4, POR, UGT1A1 and CES2 while the expression of the CES1 protein was completely knocked out. We performed transport assays using temocapril. The Papp value of temocapril in genome-edited Caco-2 cells was higher than that in WT Caco-2 cells. Interestingly, the amount of temocaprilat on the apical side in genome-edited Caco-2 cells was lower than that in WT Caco-2 cells. These results suggest that genome-edited Caco-2 cells are more suitable than WT Caco-2 cells as a model for predicting intestinal drug absorption and metabolism.

摘要

Caco-2细胞被广泛用作体外肠道模型。然而,这些细胞中药物代谢酶CYP3A4和UGT1A1的表达水平低于肠道细胞。此外,当今使用的大多数前药都是含酯类的,而羧酸酯酶(CES)1和CES2是将前药转化为药物的酶之一。在人类小肠中,CES1几乎不表达,而CES2高度表达,但Caco-2细胞中的CES表达模式则相反。在本研究中,我们使用PITCh系统生成了CYP3A4-POR-UGT1A1-CES2敲入(KI)和CES1敲除(KO)的Caco-2(基因组编辑的Caco-2)细胞。基因组编辑的Caco-2细胞显示出功能性CYP3A4、POR、UGT1A1和CES2的表达,而CES1蛋白的表达被完全敲除。我们使用替莫卡普利进行了转运试验。替莫卡普利在基因组编辑的Caco-2细胞中的表观渗透系数(Papp)值高于野生型(WT)Caco-2细胞。有趣的是,基因组编辑的Caco-2细胞顶端侧的替莫卡普利拉量低于WT Caco-2细胞。这些结果表明,基因组编辑的Caco-2细胞作为预测肠道药物吸收和代谢的模型比WT Caco-2细胞更合适。

相似文献

1
Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system.使用PITCh系统生成具有可预测的CYP3A4、UGT1A1和CES代谢的Caco-2细胞。
Drug Metab Pharmacokinet. 2023 Jun;50:100497. doi: 10.1016/j.dmpk.2023.100497. Epub 2023 Feb 18.
2
Generation of Caco-2 cells stably expressing CYP3A4·POR·UGT1A1 and CYP3A4·POR·UGT1A1*6 using a PITCh system.利用 PITCh 系统生成稳定表达 CYP3A4·POR·UGT1A1 和 CYP3A4·POR·UGT1A1*6 的 Caco-2 细胞。
Arch Toxicol. 2022 Feb;96(2):499-510. doi: 10.1007/s00204-021-03175-0. Epub 2021 Oct 16.
3
Generation and application of CES1-knockout Tet-Off-regulated CYP3A4 and UGT1A1-expressing Caco-2 cells.CES1 基因敲除 Tet-Off 调控的 CYP3A4 和 UGT1A1 表达的 Caco-2 细胞的构建及应用。
Toxicol Lett. 2024 Nov;401:158-169. doi: 10.1016/j.toxlet.2024.10.003. Epub 2024 Oct 9.
4
Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies.构建携带人肠型羧酸酯酶表达谱的Caco-2细胞系作为含酯类药物渗透性研究的有前景工具
Biol Pharm Bull. 2018;41(5):697-706. doi: 10.1248/bpb.b17-00880.
5
5-ALA treatment increases intracellular heme levels and enhances CYP3A4 activity in genome-edited Caco-2 cells.5-ALA 处理可提高基因编辑 Caco-2 细胞内的血红素水平,并增强 CYP3A4 活性。
Biochem Biophys Res Commun. 2023 Jul 5;664:94-99. doi: 10.1016/j.bbrc.2023.04.077. Epub 2023 Apr 24.
6
Evaluation of transport mechanism of prodrugs and parent drugs formed by intracellular metabolism in Caco-2 cells with modified carboxylesterase activity: temocapril as a model case.评价具有改良羧肽酶活性的 Caco-2 细胞内代谢生成的前药和母体药物的转运机制:以替莫普利为模型药物。
J Pharm Sci. 2011 Sep;100(9):3985-94. doi: 10.1002/jps.22628. Epub 2011 May 26.
7
Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells.氟西汀通过降低HepG2细胞中孕烷X受体(PXR)并增加DEC1的表达,从而降低羧酸酯酶1(CES1)、羧酸酯酶2(CES2)和细胞色素P450 3A4(CYP3A4)的表达。
Xenobiotica. 2016;46(5):393-405. doi: 10.3109/00498254.2015.1082209. Epub 2015 Sep 4.
8
The role of intestinal carboxylesterase in the oral absorption of prodrugs.肠羧酸酯酶在前药口服吸收中的作用。
Curr Drug Metab. 2010 Nov;11(9):793-805. doi: 10.2174/138920010794328904.
9
Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System.利用 PITCh 系统生成高表达多种药物代谢酶的 HepG2 细胞用于药物发现研究。
Cells. 2022 May 18;11(10):1677. doi: 10.3390/cells11101677.
10
Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.重组人羧酸酯酶的特性:荧光素二乙酸酯作为人羧酸酯酶 2 的探针底物。
Drug Metab Dispos. 2011 Aug;39(8):1329-33. doi: 10.1124/dmd.111.039628. Epub 2011 May 3.

引用本文的文献

1
Organoids and tissue/organ chips.类器官与组织/器官芯片。
Stem Cell Res Ther. 2024 Aug 5;15(1):241. doi: 10.1186/s13287-024-03859-1.